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Abstract
Background/Objectives: Pre-eclampsia (PE) is associated withprofound changes in the maternal cardiovascularsystem. The aim
of the present study was to assess whether alterations in the maternal arterial stiffness precede the onset of PE in at risk women.
Methodology/Principal Findings: This was a cross sectional study involving 70 pregnant women with normal and 70
women with abnormal uterine artery Doppler examination at 22–24 weeks of gestation. All women had their arterial
stiffness (augmentation index and pulse wave velocity of the carotid-femoral and carotid-radial parts of the arterial tree)
assessed by applanation tonometry in the second trimester of pregnancy, at the time of the uterine artery Doppler imaging.
Among the 140 women participating in the study 29 developed PE (PE group) and 111 did not (non-PE group). Compared
to the non-PE group, women that developed PE had higher central systolic (94.968.6 mmHg vs 104.3611.1 mmHg;
p=,0.01) and diastolic (64.066.0 vs 72.469.1; p,0.01) blood pressures. All the arterial stiffness indices were adjusted for
possible confounders and expressed as multiples of the median (MoM) of the non-PE group. The adjusted median
augmentation index was similar between the two groups (p=0.84). The adjusted median pulse wave velocities were higher
in the PE group compared to the non-PE group (carotid-femoral: 1.1060.14 MoMs vs 0.9960.11 MoMs; p,0.01 and carotid-
radial: 1.0860.12 MoMs vs 1.060.11 MoMs; p,0.01).
Conclusions/Significance: Increased maternal arterial stiffness, as assessed by pulse wave velocity, predates the
development of PE in at risk women.
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Introduction
Pre-eclampsia (PE), which affects 2% of pregnancies, is one of
the leading causes of maternal and perinatal mortality and
morbidity [1]. The underlying pathophysiological mechanism is
thought to be impaired trophoblastic invasion of the maternal
spiral arteries with consequent placental hypoperfusion and
hypoxia [2,3]. The abnormal trophoblastic invasion can be
detected non-invasively by Doppler examination of the uterine
arteries which, at mid-gestation, show evidence of high resistance
in 77% of cases affected by early onset severe PE [4,5].
In pregnancies withPE, there is some evidence that in addition to
the vascular changes in the uteroplacental unit there is a generalized
increase in maternal arterial stiffness [6–11]. Non-invasive assess-
ment of arterial stiffness is possible by the simple, validated and
reproducible technique of applanation tonometry with which
central blood pressures, arterial wave reflection (augmentation
index; AIx) and pulse wave velocity (PWV) of different parts of the
arterial tree can be studied [12–15]. Arterial stiffness has been
shown to be an independent predictor of cardiovascular events and
mortalityinhealthynon-pregnantsubjects[16].Sixstudies,utilizing
applanation tonometry in pregnant women with established PE,
have reported inconsistent results regarding maternal arterial
stiffness but the majority of them support the concept of increased
stiffness [6–11]. In women with PE, compared to normotensive
controls, PWV and AIx were both increased in one study [6]
whereas in a further study, none of them was increased following
adjustment for possible confounders [7]. Kaihura et al reported that
only PWV, but not AIx, was increased [8] whereas the last three
studies only assessed AIx and this was found to be elevated [9–11].
In the current study, we have used Doppler examination of the
uterine arteries in the second trimester of pregnancy in order to
identify women at risk of PE. We sought to investigate whether
altered maternal arterial stiffness at mid-pregnancy, as assessed by
applanation tonometry, precedes the onset of PE.
Materials and Methods
Ethics statement
The study was approved by the Bexley and Greenwich Local
Research Ethics Committee and all subjects gave written informed
consent prior to participation in the study.
All women attending for routine antenatal care at King’s
College Hospital have color Doppler examination of their uterine
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e18703arteries at 22–24 weeks of gestation. Trans-vaginal sonography is
performed, the left and right uterine arteries are identified by color
flow mapping, pulse wave Doppler is used to measure the
pulsatility index (PI) in each vessel and the average PI of the two
arteries (mean PI) is recorded [17]. In this study, at the time of the
uterine artery Doppler imaging we performed applanation
tonometry in 70 consecutive women with mean uterine artery PI
above the 95
th percentile of a reference group (mean PI$1.6) and
70 controls with mean PI below the 95
th percentile [17]. All 140
women had singleton pregnancies, were healthy, on no cardio-
vascular medications, had no personal history of hypertension or
family history of premature cardiovascular disease and had
appropriately grown fetuses for the gestation at the time of
scanning. Maternal age, racial origin, smoking status, parity and
body mass index (BMI) were recorded at recruitment.
Wave reflection and arterial stiffness measurements
Peripheral blood pressure (BP) was measured in the right arm
using an ambulatory blood pressure monitor (Microlife Medical
90207, WA, US), which has been validated for use in pregnancy
[18]. Systolic and diastolic BP were measured twice and averaged.
Each heartbeat generates a pulse wave that travels away from
the heart and is reflected back at the areas of high resistance. The
reflected wave travels back towards the heart and meets the
advancing wave, augmenting its height. Generally, the reflected
wave reaches the aorta during diastole, enhancing the cardiac
perfusion. When arterial stiffness in increased, the arterial pulse
wave travels faster, so the reflected wave reaches advancing wave
in the systole, resulting in significant augmentation of the systolic
peak. This can be measured as increased augmentation index
(Figure 1). Interrogation of the radial artery waveform (pulse wave
analysis of the radial artery) can provide information on
augmentation index and the central, aortic haemodynamics
[12,13,15]. Radial artery waveforms were obtained with a high-
fidelity micromanometer (SPC-301; Millar Instruments, Houston,
Tex) from the wrist, and a corresponding central waveform was
generated with a validated transfer function (Sphygmocor; AtCor
Medical, Sydney, Australia) [12,13,15]. Augmentation index, a
composite measure of systemic arterial stiffness and wave-
reflection amplitude, and central systolic, diastolic, pulse pressure
were determined with the integrated software. Due to the linear
correlation between AIx and heart rate (HR), AIx was standard-
ized to a heart rate of 75 beats per minute (bpm); AIx-75.
Information on aortic Tr (time between the start of the systolic
curve and the inflection point) was also given. Mean arterial
pressure (MAP) was obtained by integration of the waveform.
Aortic (carotid-femoral) and brachial (carotid-radial) PWV were
also measured, as previously described [14,15]. All measurements
were performed after a period of rest of at least 10 minutes in a left
lateral position in order to avoid vena cava compression by the
uterus. All measurements were made in duplicate and mean values
were used for the subsequent analyses.
Definition of outcome
The diagnosis of PE was made according to the criteria of the
International Society for the Study of Hypertension in Pregnancy
[19]. Under this classification, PE was defined as diastolic BP of at
least 110 mmHg on one occasion or diastolic BP of at least
90 mmHg on two consecutive occasions more than four hours
apart, in combination with proteinuria ($300 mg total protein in
a 24-hour urine collection or, if this was not available, $+2
proteinuria by dipstick analysis on two consecutive occasions at
least four hours apart) developing after 20 weeks of gestation in
previously normotensive women.
Statistical analysis
Normality of the distribution of the data was examined with the
Kolmogorov-Smirnov test. For those parameters that were not
normally distributed logarithmic transformation was performed.
Data were expressed as mean 6 standard deviation or as median
and interquartile range (IQR) for normally and non-normally
distributed data, respectively. Comparisons between groups were
performed using t-test, Mann-Whitney or chi-square (x
2) for
numerical and categorical data, respectively. In order to compare
the values of AIx-75 and PWV between those who subsequently
developed PE (PE group) and those who did not (non-PE group)
adjusting for variables that are known determinants of them, the
following three steps were taken: firstly, in the non-PE group
multiple regression analysis was used to determine which factors
among the maternal demographic and vascular characteristics
(maternal age, racial origin, smoking status, parity, BMI, mean
uterine artery PI on Doppler examination, HR, MAP and aortic
Tr) were significant predictors of AIx-75 and PWV (carotid-radial
and carotid-femoral); secondly, in each woman the measured
values of AIx-75 and PWVs were expressed as multiples of the
median (MoM) of the non-PE group and thirdly, the median
MoM values of AIx-75 and PWVs in the PE and non-PE groups
were compared. Power analysis indicated that a sample of 11
women with PE and similar number of controls would have an
80% power with an alpha .05 (2-tails) for the detection of a mean
difference of 1.7 m/sec in the PWV (carotid-femoral) between the
groups. The effect size was estimated from previous publications
[6,8]. The statistical analyses were performed using the Statistical
Package for Social Sciences (Version 12.0).
Results
Recordings were successfully obtained from all 140 women and
they all tolerated the studies well. One hundred and eleven women
remained normotensive (non-PE group) whereas, in 27 of the cases
in the high PI group (38.5%) and in 2 of those with normal PI
(2.8%), the pregnancies were complicated by PE. The demo-
graphic characteristics of the PE and non-PE groups are compared
in Table 1. The women in the PE group were more likely to be
black, heavier, have previous pregnancy affected by PE and more
likely to deliver smaller neonates, earlier.
Figure 1. Typical ascending aortic waveform. Typical ascending
waveform, showing two systolic peaks (P1 and P2). Augmentation index
is calculated as the difference between P2 and P1, expressed as
percentage of pulse pressure.
doi:10.1371/journal.pone.0018703.g001
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according to the Doppler examination of the uterine arteries are
given in Table 2. Pulse wave velocity, but not AIx-75, was
significantly increased in women with ultrasonographic evidence
of impaired placentation compared to women with normal
placentation. In the non-PE group multiple regression analyses
demonstrated that AIx-75 and PWV (carotid-femoral and carotid-
radial) were significantly affected by maternal demographic and
vascular characteristics as follows:
AIx-75 expected=251.72+0.616maternal age in years+
95.216log MAP265.076log aortic Tr; R
2=0.42, p,0.0001.
Maternal racial origin, smoking status, parity, BMI and mean
uterine artery PI were not significant predictors of AIx-75.
PWV (carotid-femoral) expected=28.40+0.056maternal age
in years+4.916log MAP+0.026HR+0.286mean uterine artery
PI; R
2=0.41, p,0.0001. Maternal racial origin, smoking status,
parity and BMI were not significant predictors of PWV (carotid-
femoral).






Maternal age (yrs) 30.866.3 29.465.7 0.57
Racial origin ,0.01
White, n (%) 61 (55.0) 4 (13.8)
Black, n (%) 46 (41.4) 20 (69.0)
Others, n (%) 4 (3.6) 5 (17.2)
Smoking, n (%) 21 (18.9) 7 (24.1) 0.73
Nulliparity, n (%) 60 (54.1) 14 (48.3) 0.57
Maternal height (m) 1.660.05 1.660.05 0.80
Maternal weight (kg) 70.9610.7 78.3612.9 ,0.01
Body mass index (kg/m
2) 26.764.1 29.464.4 ,0.01
Previous history of pre-eclampsia, n (%) 2 (1.8) 4 (13.8) ,0.01
Gestational age at entry (days) 161 (160–166) 163 (161–169) 0.04
Gestational age at delivery (days) 279 (270–285) 245 (220–267) 0.01
Birth weight (gr) 3216 (2781–3540) 2190 (1363–2779) .01
Values are given as mean 6 standard deviation or as median (interquartile range) for normally and not normally distributed data respectively.
doi:10.1371/journal.pone.0018703.t001









Mean uterine artery PI 0.99 (0.83–1.12) 1.82 (1.73–2.03) ,0.01
Heart rate (bpm) 76.969.9 74.9610.0 0.22
Heart cycle (ms) 792.26102.6 815.16107.9 0.20
Ejection duration (msec) 326.9622.1 324.6623.1 0.53
Diastole time (msec) 465.2691.1 490.4691.3 0.10
Peripheral systolic blood pressure (mmHg) 115.468.7 115.8610.8 0.79
Peripheral diastolic blood pressure (mmHg) 67.067.0 66.868.0 0.83
Mean arterial pressure (mmHg) 77.7 (74.3–81.5) 79.2 (74.8–86.2) 0.25
Peripheral pulse pressure (mmHg) 48.366.7 49.068.6 0.59
Central systolic blood pressure (mmHg) 95.868.5 98.0611.1 0.19
Central diastolic blood pressure (mmHg) 65.165.8 66.468.9 0.32
Central pulse pressure (mmHg) 30.666.0 31.565.9 0.36
Aortic Tr (msec) 157.7 (147.5–177.6) 152.7 (146.3–170.2) 0.35
Augmentation Index (%) at 75 bpm 5.2 (25.1–13.0) 5.7 (23.6–12.1) 0.44
Pulse wave velocity (carotid-femoral) (m/sec) 5.060.6 5.560.9 ,0.01
Pulse wave velocity (carotid-radial) (m/sec) 7.461.0 7.961.0 0.01
Values are given as mean 6 standard deviation or as median (interquartile range) for normally and not normally distributed data respectively.
doi:10.1371/journal.pone.0018703.t002
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years+5.576log MAP+(21.86 if the racial origin was White,
21.33 if Black, 0 if other); R
2=0.23, p,0.0001. Maternal
smoking status, parity, BMI and mean uterine artery PI were not
significant predictors of PWV (carotid-radial).
Hemodynamic and vascular parameters in the PE group
The hemodynamic and vascular parameters of the study groups
according to the outcome of pregnancy are given in Table S1. The
median adjusted AIx-75 was not significantly different between the
PE and non-PE groups. Conversely, the peripheral and central,
systolic, diastolic and mean BP and adjusted PWV (carotid-
femoral and carotid-radial) were increased in the PE group
(Figure 2). Within the PE group, there was no statistical significant
difference in the adjusted PWV’s between the women with normal
(n=2) and those with abnormal (n=27) uterine artery Doppler
examination (p.0.05). In the PE group, there was no significant
association between gestation at delivery and peripheral systolic
BP (p=0.41), peripheral diastolic BP (p=0.15), central systolic BP
(p=0.22), central diastolic BP (p=0.369) and MAP (p=0.26).
There was no statistically significant difference in the adjusted
median PWV (carotid-femoral) values between women with early
onset PE, requiring delivery prior to 34 weeks, compared to those
with late onset disease (1.1360.14 MoMs vs 1.0760.14 MoMs;
p=0.28) or between those with concurrent fetal growth restriction
and those without (p=0.48).
Discussion
The findings of this study demonstrate that in women destined
to develop PE, during the second-trimester of pregnancy there is
an increase in maternal arterial stiffness as assessed by PWV of the
carotid-femoral and carotid-radial parts of the arterial tree. The
magnitude of the PWV increase of about 17% is similar to that
reported in women with established PE [6,8] and although small,
is likely to be clinically significant considering the fact that aortic
PWV increases by only ,6% per decade in healthy individuals
[20].
Overall, women with impaired placentation, as detected by
Doppler examination of the uterine arteries, had increased arterial
stiffness (PWV) suggesting that women at risk of developing PE
have a high resistance circulation affecting different vascular beds
including the fetoplacental unit and the maternal conduit arteries.
It is likely that other, multiple factors such as maternal genetic
susceptibility will eventually determine which women will develop
PE. Mean uterine artery PI was a significant independent
predictor of PWV but despite that, PWV was still increased in
women who subsequently developed PE implying that this
vascular index provides additional information regarding the
maternal cardiovascular adaptation to pregnancy over and above
the Doppler examination of the uterine arteries.
The increased maternal arterial stiffness in women destined to
develop PE may be related to the aberrant maternal physiological
and biochemical adaptation to pregnancy that these women
demonstrate. Maternal endothelial dysfunction, as assessed by
flow-mediated dilatation of the brachial artery [21], increased
levels of asymmetric dimethyl-arginine, an endogenous inhibitor of
nitric oxide synthase [21], elevated concentrations of homocyste-
ine and marked insulin resistance are all features of the pre-clinical
state of PE [22,23] and have also been shown to be associated with
increased arterial stiffness [24,25]. However, it is uncertain
whether all these factors including maternal arterial stiffness are
Figure 2. Pulse wave velocity in the study populations. Box and whisker plots comparing the maternal pulse wave velocity of the carotid-
femoral and carotid-radial parts of the arterial tree, expressed as multiples of the median (MoM) in women who subsequently developed pre-
eclampsia (PE group) and in the non-preeclampsia group (Non-PE group). Boxes represent inter-quartile range, where the line represents the median.
Whiskers at top and bottom of the box represent the highest and lowest values.
doi:10.1371/journal.pone.0018703.g002
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underlying pathophysiological mechanisms of PE. Only studies in
women prior, during and following pregnancy will be able to
address this question.
Previous studies have shown that in non-pregnant populations
increased PWV is predictive of cardiovascular mortality [16].
Furthermore, studies in women with established and previous
history of PE have shown increased maternal arterial stiffness, as
assessed by PWV [6–11,26]. Our study, which is the first to assess
maternal PWV prior to the clinical manifestation of PE, is also
consistent with the above findings. Consequently, it could be
hypothesised that increased arterial stiffness, as assessed by PWV,
provides a plausible link between the development of PE in the
index pregnancy and the increased propensity to cardiovascular
events that these women experience later on in life [27]. Only
studies assessing maternal arterial stiffness prior to, during and
many years following a pregnancy complicated by PE can confirm
the above concept.
In addition to increased arterial stiffness, women who
subsequently developed PE demonstrated increased peripheral
and central BP. Studies in non-pregnant hypertensive patients
have shown that central and peripheral BP are not synonymous
and antihypertensive agents can exert differential effects on the
two types of BP [28]. In patients with end-stage renal disease,
central aortic pulse pressure was of greater predictive value for
cardiovascular outcomes than brachial pulse pressure [28,29].
Previous studies assessing peripheral BP have reported that in
women destined to develop PE, the BP is higher than in the non-
PE group both during the second but also in the first-trimester of
pregnancy [30]. It would be interesting to investigate the extent to
which the prediction of PE can be improved by the measurement
of central rather than peripheral BP.
In contrast to PWV, there were no significant differences in the
AIx between the PE and non-PE groups. This is compatible with
the results of our previous study in women with established PE
where there was an increase in PWV but not in AIx [8]. However,
it is in contrast with other studies that suggested that AIx is
elevated in women with established PE [6,9–11] and one study
that suggested that AIx could be used as a first trimester predictor
of PE [31]. Augmentation index provides an indirect measure of
arterial stiffness and in both healthy individuals and in those with a
disease such as hypercholesterolemia [32] and essential hyperten-
sion [33], there is usually an association between PWV and AIx.
However, AIx depends on the intensity of the reflected wave and
as such it will depend on the diameter and elasticity of the small
muscular arteries/arterioles at the major sites of pressure wave
reflection. Therefore, alterations in muscular smooth muscle tone
affecting mainly the small muscular arteries but not the elastic
aorta might influence reflected wave intensity and hence AIx
independently of PWV. In accordance to this, administration of
vasoactive substances will affect AIx and PWV differently [34].
Furthermore, the dissociation between PWV and AIx observed in
our study has also been described in individuals with metabolic
syndrome [35], a condition that is also present in a number of
women who develop PE [23].
The aim of the current study was to investigate the maternal
cardiovascular adaptation and in particular arterial stiffness in
women destined to develop PE and not to assess whether arterial
stiffness indices could be used as predictors of PE development.
Therefore, we did not attempt to create predictive models and
receiver-operating characteristics curve analysis. Furthermore, this
was a cross-sectional study and as such we cannot comment on the
longitudinal changes of maternal arterial stiffness during pregnan-
cy complicated by PE. However, our results should encourage
further research, involving larger number of women, to establish
the predictive value of PWV in PE development and its use in
patient’s management.
The study demonstrated significant maternal hemodynamic/
arterial stiffness differences between women destined to develop
PE and those did not. The extent to which arterial stiffness is useful
in screening for PE in unselected and high risk populations
remains to be determined.
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